|
Delayed
Bombay S.E.
14:02:29 22/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 53.00 INR | -1.56% |
|
-9.17% | +1,077.78% |
Company Valuation: Rekvina Laboratories Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Market Cap 1 | 27.13 | 27.13 | 27.13 | 27.13 | 217.9 |
| Change | - | 0% | 0% | 0% | 703.33% |
| Enterprise Value (EV) 1 | 27.12 | 27.84 | 27.92 | 29.34 | 232.5 |
| Change | - | 2.65% | 0.3% | 5.09% | 692.28% |
| P/E | -34.6x | -3,641x | -167x | -19.6x | -85.6x |
| PBR | 196x | 206x | -848x | -8.17x | -17.7x |
| PEG | - | 36.8x | -0x | -0x | -1x |
| Capitalization / Revenue | - | - | - | - | 17,220,816x |
| EV / Revenue | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - |
| EV / EBIT | -35.9x | -685x | -170x | -21.4x | -91.3x |
| EV / FCF | -237x | -37.8x | -1,299x | -20.9x | -46.6x |
| FCF Yield | -0.42% | -2.65% | -0.08% | -4.79% | -2.15% |
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | -0.13 | -0.001236 | -0.027 | -0.23 | -0.4225 |
| Distribution rate | - | - | - | - | - |
| Net sales | - | - | - | - | 12.65 |
| EBITDA | - | - | - | - | - |
| EBIT 1 | -0.755 | -0.0406 | -0.164 | -1.371 | -2.547 |
| Net income 1 | -0.7888 | -0.007452 | -0.164 | -1.371 | -2.547 |
| Net Debt 1 | -0.00368 | 0.7155 | 0.798 | 2.218 | 14.57 |
| Reference price 2 | 4.50 | 4.50 | 4.50 | 4.50 | 36.15 |
| Nbr of stocks (in thousands) | 6,028 | 6,028 | 6,028 | 6,028 | 6,028 |
| Announcement Date | 06/09/23 | 06/09/23 | 15/07/24 | 01/09/25 | 03/09/26 |
1INR in Million2INR
Estimates
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- VINRKLB Stock
- Valuation Rekvina Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
